The objective of this study was to test the relationship between histological changes in minor salivary glands (MSG) and chronic GVHD (cGVHD) severity and OS of hematopoietic SCT (HSCT) patients, and to discriminate the participation of events preceding HSCT that damage MSG, from those linked to cGVHD. The MSG of 57 HSCT patients who were divided into two groups-oral cGVHD (36 cases) and non-cGVHD (21 cases)-were compared with the MSG of a control group of 19 non-HSCT individuals. cGVHD changes were assessed according to National Institutes of Health (NIH) consensus and the systems of Horn et al. Acinar areas and mononuclear cell subsets were set through morphometry. Horn's 'periductal lymphocytic infiltrate' correlated with an extensive form of cGVHD and NIH 'periductal lymphocytes with exocytosis into duct' correlated with global survival. Measurements of the acinar area differed between the three groups, being the lowest in cGVHD patients, but also reduced in non-cGVHD patients. Significant differences among CD45, CD45RO, CD4 and CD8 immunomarked cells/mm 2 were found by comparing the two groups of HSCT patients. In brief, periductal lymphocytic infiltrate and exocytosis implies inflammatory activity and, consequently, might reflect the cGVHD status and influence survival. Acini loss in non-cGVHD patients may be due to pre-transplant events, but massive lymphocyte infiltrate is part of the cGVHD process.
INTRODUCTION
The oral cavity is frequently the primary source of hematopoietic SCT (HSCT) morbidity. 1 Saliva has a major role in maintaining oral health and function. 2 The loss of saliva leads to increased risk of dental caries, periodontitis, candidal superinfections, oral pain, friability and food sensitivity. Additionally, difficulties in speaking, chewing and swallowing, as well as weight loss, can also emerge. 3, 4 Both prior HSCT-conditioning regimens and chronic GVHD (cGVHD) can cause salivary gland damage and inflammation, leading to xerostomia. 5 cGVHD is the major late complication of HSCT. It is mediated by T lymphocytes targeting various organs and tissues, including the oral mucosa and salivary glands, leading to salivary hypofunction and oral damage. 6 The oral cavity may be the principal or sole site of involvement in 50-83% of those affected by cGVHD. 7 On a clinical basis, mucosal lesions, salivary gland dysfunction and taste disorders are similar to those of autoimmune disorders such as lichen planus, lupus and Sjö gren syndrome. [7] [8] [9] The typical histological findings of cGVHD in salivary glands are periductal and diffuse lobular lymphocyte infiltrate (CD8 þ over CD4 þ ), atrophy or destruction of acini, and fibrosis. 5, [10] [11] [12] [13] [14] [15] Despite the advent of new therapies and management of cGVHD, minimal changes in this scenario have been observed, mainly due to an incomplete understanding of the pathogenesis of this disorder. 1, 16 Knowing the most important histological findings for the diagnosis of minor salivary gland (MSG) cGVHD and its possible influence on overall patient health and understanding the mononuclear subset participation in salivary glands after HSCT can contribute to better management of those patients.
We assessed the cGVHD histological changes, according to the National Institutes of Health (NIH) consensus and the systems of Horn et al., the residual acinar area and lobular mononuclear cell subsets in the MSG of HSCT patients. Our aim was to test their potential relation with cGVHD severity and the OS of patients, and to improve the understanding of the relative participation of events preceding HSCT that damage the MSG.
PATIENTS AND METHODS
This is a retrospective analysis of patients who underwent conventional HLA-matched HSCT from sibling donors. After searching the database of the Bone Marrow Transplantation Unit of the State University of Campinas, between 1994 and 2004, 316 patients were found. All of them regularly underwent oral examination at the Odontology Division. Fifty-seven patients submitted to the myeloablative HSCT; those who fulfilled the inclusion criteria were selected. Inclusion criteria were the complete medical history and a lip biopsy, with MSG represented. Exclusion criteria were incomplete follow-up data and unavailable or insufficient paraffin material for new cuts. Beside myeloablative drugs, five of them had been submitted to TBI (12 Gy).
Fifty-seven patients were divided into two groups: 36 patients with chronic oral GVHD comprised the first group, and 21 patients who never developed GVHD comprised the second group. The control group consisted of 19 MSG found in lip specimens with surgically removed benign conditions, such as lentiginous macules, nevi and cysts. Other organs with cGVHD involvement in the first group of patients could include skin, liver and eyes. Sixty per cent of GVHD patients presented signs of xerostomy and 57% of them presented lichenoid lesion.
In conformity to the standard protocol of Universidade Estadual de Campinas UNICAMP BMT Unit, the biopsy specimens were obtained on the day on which the disease was clinically diagnosed, or on day þ 100 post HSCT of all patients who consented to the procedure (in this case, always from lower inner lip, about 10 mm beneath the vermilion border, through a 4 mm-punch, under local anesthesia). The average time interval of performing biopsy after BMT was 125 (77-1681) days.
cGVHD involvement, at the time when patients were being followed, was classified as limited or extensive, according to Shulman et al., 17 since the NIH severity scoring had not yet been published. Patients' clinical data are summarized in Table 1 .
Paraffin-embedded tissue was serially sectioned at 4 mm thickness and stained with hematoxylin and eosin stain and periodic acid Schiff (PAS). All specimens were assessed for histological cGVHD features according to: 1. the NIH consensus pathology working group (Table 2) 15 and 2. Horn et al.
18
grading systems (Table 2) . Two pathologists (TCBS and MLC) blindly read the sections. An immunohistochemical study was performed using the standard polymeric method. Briefly, the histological sections were deparaffinized in xylene and rehydrated. The primary monoclonal antibodies used were: CD4 (clone OPD4 at a dilution of 1:100), CD8 (clone C8/144B, at a dilution of 1:200), CD45 (clone 2B11 þ PD7/26, at a dilution of 1:500), CD45RO (clone UHCL-1, at a dilution of 1:700), CD68 (clone KP1, at a dilution of 1:700) and CD138 (clone MI15, at a dilution of 1:200), all distributed by DAKO (Dako Cytomation, Carpinteria, CA, USA). A steamer was used for epitope retrieval and the EnVision polymer (DAKO) as the reaction amplifier. Appropriate positive and negative controls were included in each essay. Staining was achieved with 3,3-diaminobenzidine tetrahydrochloride (Sigma, St Louis, MO, USA) and counterstaining with Mayer's haematoxylin. Sections with folds, ruptures, strong background staining or weak target Ag-staining were excluded, and the procedures were repeated. Even so, some specimens could not be included for morphometric study. This explains why the patient numbers in Table 3 for the various cellular subsets are different from the total patient number.
A quantitative analysis was performed using Â 400 digital images in 10 random fields, either for PAS-or for immunostained sections of each patient. The 10 analyzed fields represented around 10% of the total area of the histological section, corresponding to an area of 0.380 mm 2 . The number of ducts with lymphocytes in exocytosis into epithelium/mm 2 was also recorded using an Olympus CH30 optical microscope (Olympus, Center Valley, PA, USA), in high ( Â 400) magnification in the CD45-stained sections.
For the morphometric study, PAS-stained digital images were analyzed using the ImageJ software (Wayne Rasband, NIH, Bethesda, MD, USA). The digital images were segmented according to the color spectrum and the targeted area was calculated, providing the value of PAS þ area/total area ratio. Digital images from immune-marked samples were analyzed using 19 Cox regression analysis, 20 with the backward-stepwise Wald test considering P-value o0.05 was used to search predictor variables in the OS. The following variables were included in the models for their putative impact on survival, clinical (Table 1 ) and histological features (Table 2) , all cell subsets (CD4 þ ; CD8 þ ; CD45 þ ; CD45RO; CD68 þ ; CD138 þ ) and PAS data (Table 3) .
This study was approved by the Research Ethics Committee of the Faculty of Medical Sciences, University of Campinas (process 598/2002). Table 3 shows the comparative analysis of the immunostained inflammatory cell subset relative numbers and PAS þ relative acinar area in minor salivary glands of HSCT patients and healthy individuals.
RESULTS
The OS rates of cGVHD and non-cGVHD patients was found to be very similar (66% versus 62% P ¼ NS). However, in the cGVHD group, most of the deaths were recorded after the first year post HSCT, whereas, in the other group, they were recorded during the first year post HSCT (Figure 1) .
The histological cGVHD feature presenting the highest influence on global survival (P ¼ 0.005) was the NIH feature 'periductal lymphocytes only with exocytosis into duct' (Figure 3) , confirmed through the univariate Cox analysis (hazard ratio 10.4, P ¼ 0.02, 95% confidence interval 1.34-81.4).
The objective counting of the relative number of ducts with lymphocyte exocytosis displayed a significant correlation with the subjective evaluation of the presence (or absence) of the NIH feature 'periductal lymphocytes only with exocytosis into duct' (P ¼ 0.004). After applying several tests and comparing patients with localized or extensive cGVHD, no significant differences were found in the number of ducts with exocytosis.
Concerning the NIH feature 'acinar degeneration/interstitial fibrosis/ductal ectasia', significant differences were found between patients who had extensive cGVHD and those who did not (P ¼ 0.03). However, Horn's feature 'ductal dilation', as an isolated criterion, did not correlate with the cGVHD clinical form (Pearson's correlation). Moreover, no significant difference in the degree of ductal dilation was found, comparing patients who developed cGVHD and those who did not. Horn's 'periductal lymphocytic infiltrate' finding was most closely related to the clinical extensive form of cGVHD (P ¼ 0.04).
On comparing the two groups of HSCT patients, significant differences were observed among the relative number of CD45-, CD45RO-, CD4-and CD8-positive cells. However, no differences were found between the control group and the non-cGVHD patients for the same markers. For CD68, we found no differences between the two groups of HSCT patients, but there were significant differences between the values of control group individuals and non-cGVHD patients. The PAS þ relative acinar area exhibited significant differences when the three groups were compared with each other (Figure 2) . So, functional acinar loss evolved after HSCT even in patients who did not develop cGVHD, although to a lesser degree. These results are summarized in Table 3 . No differences were found for CD138 þ cells by comparing the three groups of individuals.
DISCUSSION
The histopathological examination can aid in MSG cGVHD diagnosis, ruling out infections with atypical clinical features. 21 Correa et al. 22 found an association between the involvement of MSG and oral mucosa in cGVHD after HSCT and the decrease in patient survival. The histological features that have been reported to be associated with cGVHD on MSG are lobular and periductal lymphocytic infiltrate, acinar atrophy/destruction, and fibrosis. [10] [11] [12] Horn et al. 18 in 1995, proposed a system for mucosal and salivary gland cGVHD diagnosis and grading. After comprehensive discussions among HSCT experts, the NIH consensus criteria for Relative area (PAS þ area/total MSG area). clinical trials in cGVHD was issued, defining the most important diagnostic criteria for cGVHD. The recommendations of this group were published by Shulman et al. 15 in 2006. With the aim of testing the value of the described features in predicting cGVHD severity and the OS of patients, we assessed all the criteria reported by Horn and Shulman (Table 2 ) on the MSG specimens of the three groups of individuals. The NIH 'periductal lymphocytes only with exocytosis into duct' (Figure 3) , feature was found to be correlated with the OS of cGVHD patients. Lymphocyte exocytosis reflects high inflammatory activity and, consequently, progressive acinar loss. Xerostomia can be a distressing symptom, and decreased salivary flow may lead to reduced food intake, dental caries, and oral mucosal infection. 23 Oral dryness is associated with a lower health-related quality of life 24 and can be an additional factor in the reduction of the OS of these patients. Although these results should be regarded with caution due to the small number of patients in our cohort, they stress the importance of improving the management of oral cGVHD inflammation in long-term survivors of allogeneic HSCT. It is necessary to validate these results by studying a larger series of patients from different institutions. Significant correlation was also found between the objective counting of ducts with exocytosis and the subjective assessment (presence or absence) of the 'periductal lymphocytes only with exocytosis into duct'. Therefore, the subjective evaluation can be considered reliable. However, the relative number of ducts with exocytosis displayed no prognostic relevance. We believe that these results can be explained by the staining used for evaluation. The subjective feature was assessed on hematoxylin and eosin stain samples, and only cases with significant lymphocyte exocytosis could be discerned. The counting of ducts with exocytosis was performed on CD45-immunolabeled specimens that allowed easy identification of inflammatory cells permeating the ductal epithelium, even when sparse. Therefore, the prognostic value of periductal lymphocytes permeating the epithelium depends on the inflammatory severity.
Regarding systemic cGVHD involvement, Horn's 'periductal lymphocytic infiltrate' feature was found to best correlate with the clinical extensive form of cGVHD. In fact, oral cGVHD often coexists with cutaneous, hepatic or ocular cGVHD. 25 According to Nakamura et al.,
10 the histological alterations in MSG can reflect the cGVHD status. 10 Ductal dilation has been described as one of the histological findings for cGVHD diagnosis. [10] [11] [12] 18 However, it could only be the consequence of acinar atrophy and fibrosis due to the conditioning regimen. In fact, no significant differences were found in the degree of ductal dilation, comparing patients who developed cGVHD and those who did not. On the other hand, when ductal dilation, fibrosis and acinar degeneration were assessed together, as recommended by Shulman et al., 15 significant differences were found between cGVHD and noncGVHD patient samples. This reiterates that the tissue destruction caused by T-cell infiltrates is more important than the simple presence of ductal dilation.
Concerning immunohistochemical analysis, we found a significant increase of CD45 þ , CD45RO þ , CD4 þ and CD8 þ cells in the MSG of cGVHD patients, with a predominance of CD8 over the CD4 phenotype, comparatively with the other two groups. These results reiterate the T cells' role in the pathogenesis of cGVHD. However, no differences were found between the control group (non-HSCT patients) and the non-cGVHD patients for the same markers. Therefore, we can infer that the massive lymphocyte infiltrate was a part of the cGVHD process and not of the chemoradiotherapy regimen preceding HSCT. Our results also revealed that the lymphocyte infiltrate related to cGVHD is not the only mechanism for salivary cell loss in HSCT patients. The PAS þ acinar area exhibited significant differences when the three groups were compared with each other. The loss of functional acini is probably due to the cytotoxicity of antineoplastic and pre-transplant conditioning drugs and progresses with the cGVHD process. In fact, conditioning regimens have been shown to promote oral toxicity and also injure salivary glands, 26 which justifies xerostomia in post-HSCT patients even when they do not develop cGVHD. The PAS relative area in non-HSCT patients corresponded to 36% of the glandular parenchyma; in HSCT patients who did not develop cGVHD, it corresponded to 25%; and in cGVHD patients, it corresponded to 3% of glandular parenchyma. Severe involvement of the MSG in cGVHD results in marked destruction of the secretory units and, thus, in permanent and profound oral dryness. 27, 28 Unlike our results, Soares et al.
14 found increased CD68 þ cell number in cGVHD patients, compared with non-cGVHD HSCT patients. This discrepancy might be explained by the previous development of acute GVHD. In our cGVHD cohort, only four patients previously developed acute GVHD. In the third phase of acute GVHD, allogeneic activated T cells travel to the target tissues, and inflammation and tissue destruction occurs. 29, 30 Donor CD4 þ T cells can interact with donor macrophages, which present recipient Ags. Tissue macrophages can also induce donor CD4
þ T cells to produce inflammatory mediators that activate macrophages. 31 Significant differences were found in relative CD68 þ cell numbers, comparing control group and non-cGVHD patients. Normal lymphoid tissue is destroyed in the pre-transplant conditioning; following the HSCT, immune reconstitution takes place, and successful reconstruction of the T-cell compartment is known to require 1-2 years. 32 However, monocytes and natural killer cells reach the normal range by day 30. 33 All our HSCT non-GVHD biopsies were collected around day 100 post HSCT, when the T cells had not yet fully recovered, and therefore, were not in a greater number. However, the macrophages had already been reconstituted, and the chemical mediators released during the pre-transplant conditioning recruit these cells.
In our cohort, plasma cells (CD138 þ cells) contributed a significant part of the infiltrate, although we found no differences in CD138 þ cell relative numbers when the three groups were compared. The MSGs of the control group of our cohort were obtained from free surgical margins of biopsies of non-inflammatory lesions in the lip. It is possible that, although not in direct contact, the proximity with these benign lesions may have resulted in the increase in the number of inflammatory cells in these glands.
In short, periductal lymphocytic infiltrate and lymphocyte exocytosis implies high inflammatory activity and, consequently, might reflect the cGVHD status. The graft that lymphocytes attack would not be restricted to salivary ducts, but would also occur in other body structures, possibly exerting negative influence on OS. The loss of functional acini in non-cGVHD patients may be due to the cytotoxicity of pre-transplant drugs, but the massive lymphocyte infiltrate is part of the cGVHD process.
